Cancer - Y-mAbs Therapeutics

Cancer

Status:

Active, not yet recruiting

ClinicalTrials.gov:

NCT05994157

Phase 1, Open-label, Dose-escalation Trial with CD38-SADA:177 Lu-DOTA Drug Complex in Subjects with Relapsed or Refractory Non-Hodgkin Lymphoma

Drug

CD38-SADA

Condition

Non-Hodgkin Lymphoma